The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research.
UK MHRA · January 13, 2026
Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
Original title: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.